DHER34:BVMF
Danaher Corporation Bdr
R$39,72
arrow_downward
-1,19%(-0,48) 1D
5 ຕ.ລ., 16 ໂມງ 38 ນາທີ 32 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$38,95
High
R$39,72
Low
R$38,30
Mkt. cap
154,78 ຕື້
Avg. vol.
2,47 ພັນ
Volume
19,00
52-wk high
R$45,87
52-wk low
R$27,94
Shares outstanding
702,99 ລ້ານ
No. of employees
59 ພັນ
Open
R$38,95
High
R$39,72
Low
R$38,30
Mkt. cap
154,78 ຕື້
Avg. vol.
2,47 ພັນ
Volume
19,00
52-wk high
R$45,87
52-wk low
R$27,94
Shares outstanding
702,99 ລ້ານ
No. of employees
59 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
27 ນາທີກ່ອນ
Danaher Has Barely Moved in a Year. Is its 25x Earnings Valuation Justified?
TradingKey
·
40 ນາທີກ່ອນ
Danaher Corp Stock (DHR) Moved Up by 3.32% on Oct 5: What Investors Need To Know
Yahoo Finance
·
4 ຊົ່ວໂມງກ່ອນ
Danaher's Multiple Now in Line With Peers, RBC Says
Investing.com
·
5 ຊົ່ວໂມງກ່ອນ
RBC Capital raises Danaher stock price target on peer valuation
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr